Evidence map›Paper›PMID 40887984›Full record

ArticleEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology2025

A preclinical study of combined hepatic and renal artery denervation.

Felix Mahfoud, Stefan Tunev, David E Kandzari, Eric A Secemsky, Pam R Taub, Raven A Voora, Lucas Lauder, Cian Ryan, Julie Trudel, Douglas A Hettrick and 1 more

Abstract read
In one paragraph

Article in EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Periarterial nerves along the human hepatic artery: anatomical determinants for cardiometabolic neuromodulation.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Felix MahfoudDepartment of Cardiology, Department of Biomedical Engineering, and Department of Biomedicine, University Heart Center, University Hospital Basel, Basel, Switzerland.
Stefan TunevMedtronic, Santa Rosa, CA, USA.
David E KandzariDepartment of Cardiology, Piedmont Heart Institute, Atlanta, GA, USA.
Eric A SecemskyDivision of Cardiology, Department of Medicine, Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Boston, MA, USA and Harvard Medical School, Boston, MA, USA.
Pam R TaubDivision of Cardiovascular Medicine, Department of Medicine, University of California, San Diego, CA, USA.
Raven A VooraDepartment of Medicine, Division of Nephrology and Hypertension, University of North Carolina, Chapel Hill, NC, USA.
Lucas LauderDepartment of Cardiology, Department of Biomedical Engineering, and Department of Biomedicine, University Heart Center, University Hospital Basel, Basel, Switzerland.
Cian RyanMedtronic, Santa Rosa, CA, USA.
Julie TrudelMedtronic, Santa Rosa, CA, USA.
Douglas A HettrickMedtronic, Santa Rosa, CA, USA.
Markus SchlaichDobney Hypertension Centre, Medical School - Royal Perth Hospital Unit and RPH Research Foundation, The University of Western Australia, Perth, WA, Australia and Department of Cardiology and Department of Nephrology, Royal Perth Hospital, Perth, WA, Australia.

Funding

Impact of Time-Restricted Feeding (TRF) on Glucose Homeostasis and Mitochondrial Function in Patients with Metabolic SyndromeR01DK118278 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Pam Rajendran Taub · 2018 to 2026
$5.3M
HL-132: Increasing Adherence to Guideline-Based Exercise Therapy For Chronic Heart FailureR01HL136407 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MILLS, PAUL J · 2018 to 2022
$4.0M
Shared Decision-Making to Improve the Health Status of Patients with Claudication: Developing and Implementing Strategies to Individualize Treatment DecisionsK23HL150290 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SECEMSKY, ERIC ALEXANDER · 2020 to 2024
$851k
NHLBI NIH HHS K23 HL150290NHLBI NIH HHS R01 HL136407NIDDK NIH HHS R01 DK118278
6 · The paper itself

Abstract

backgroundOveractivity of the hepatic and renal sympathetic nerves is associated with chronic cardiovascular and metabolic conditions, including hypertension.

aimsWe studied the effect of combined renal and hepatic denervation through treatment of the common hepatic artery and the renal arteries.

methodsDenervation was performed in the common hepatic artery and both renal arteries and their major branch vessels in normotensive swine using the same multielectrode radiofrequency (RF) ablation catheter (Symplicity Spyral). Renal and liver tissue samples were obtained for histological examination in two cohorts at 7 and 28 days post-procedure (n=5 sham, n=10 denervation for each timepoint).

resultsCombined hepatic and renal denervation was successfully achieved in all animals. At 7 days, the mean lesion depth was 5.8±1.4 mm in the renal arteries and 4.7±0.7 mm in the hepatic artery. Compared with controls, the mean renal cortical norepinephrine (NE) levels were reduced by 88.2% in the 7-day model and by 84.5% in the 28-day model. Liver NE decreased by 94.6% at 7 days and by 91.1% at 28 days (p<0.0001 for all comparisons with baseline). No inadvertent injury was detected in the treated arteries or adjacent tissues.

conclusionsCombined hepatic and renal denervation using the same multielectrode RF denervation system resulted in a substantial reduction in both renal and hepatic tissue NE levels that was sustained up to 28 days without collateral tissue injury. These mechanistic findings may have implications for the treatment of chronic diseases impacted by hepatic and renal sympathetic nervous system overactivity.

Indexed as

Catheter AblationHepatic ArteryKidneyLiverRenal ArterySympathectomyAnimalsNorepinephrineSwineNorepinephrine

Identifiers

PMID40887984
PMCPMC12379030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.